Press Releases

Thermo Fisher Scientific Introduces Hematology-Oncology Portfolio for Ion Torrent Genexus System

In hematology oncology, it is critically important to understand the genetics driving acute malignancies to quickly determine how best to address the disease. Today, Thermo Fisher Scientific announces a new portfolio of hematology-oncology assays for the Ion Torrent Genexus...

Catalent Signs Agreement with AstraZeneca to Expand Manufacturing Support for COVID-19 Vaccine AZD1222

Catalent, Inc., the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, announced that Catalent Cell & Gene Therapy will provide drug substance manufacturing to AstraZeneca...

PharmaSources.com to Help Propel the Chinese API Export Business with E-Trade Session CPhI China Top API Exporters & Products

PharmaSources.com, the vertical B2B portal for the pharmaceutical industry, announces the launch of the virtual session CPhI China Top API Exporters & Products on 24-28 August 2020, as part of the CPhI & P-MEC China E-Trade Season (August to...

PharmaSources Launches the Export-Driven Event CPhI & P-MEC China E-Trade Season

PharmaSources, an international B2B trade portal for the pharmaceutical verticals, is launching the virtual event CPhI & P-MEC China E-Trade Season from August to December 2020. Consisting of the three sessions "Top API Exporters & Products", "Popular Natural Extracts...

Cryoport Expands Global Supply Chain Platform by Signing Agreement to Acquire CRYOPDP

Cryoport, Inc., a global leader in temperature-controlled supply chain solutions for the life sciences industry, announced the expansion of its global supply chain network and services by signing an agreement to acquire CRYOPDP, a leading global provider of innovative...

Pharmaceutical Packaging And Manufacturing Trends To Be Covered By PHARMAP 2021

Pharmaceutical Manufacturing & Packaging Congress (PHARMAP 2021) will cover the topics of cutting-edge technologies and digitalization in the Manufacturing and Packaging processes of the pharmaceutical industry. It will take place in Berlin, Germany on the 7-8 of June 2021....

Byondis Initiates Phase I Study of Antibody-Drug Conjugate SYD1875

Byondis B.V. (formerly Synthon Biopharmaceuticals B.V.) announced that the first cancer patients have started treatment with its investigational antibody-drug conjugate (ADC) SYD1875. The First-in-Human Dose-Escalation and Expansion Study with the Antibody-Drug Conjugate SYD1875 will evaluate the safety, pharmacokinetics and preliminary...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read